Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis.

Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis.
复制标题

DOI:
10.1002/hep.26556
复制
发表时间:
2014-04
期刊:
影响因子:
13.5
通讯作者:
Magder, Laurence S.
Magder, Laurence S.
中科院分区:
医学1区
文献类型:
--
作者:
Mindikoglu, Ayse L.;Dowling, Thomas C.;Weir, Matthew R.;Seliger, Stephen L.;Christenson, Robert H.;Magder, Laurence S.

文献摘要

参考文献

被引文献

相似文献

传统的以肌酐为基础的肾小球滤过率(GFR)公式不能很准确地估计肝硬变患者的GFR。慢性肾脏疾病流行病学协作组(CKD-EPI)最近提出了一个公式,可以同时使用血清肌酐和胱抑素C水平来估计非肝硬化组的GFR。新的CKD-EPI肌酐-胱抑素C方程(2012)的性能优于以前基于肌酐或胱抑素C的GFR方程。为了评价CKD-EPI肌酸-胱抑素C方程在肝硬变患者中的应用,我们比较了72例肝硬变患者的CKD-EPI肌酸-胱抑素C方程与非放射性标记硫代氨基甲酸盐血浆清除率(MGFR)测定的GFR。我们比较了新的CKD-EPI肌酐-胱抑素C方程与24小时尿肌酐清除量(CrCl)、Cockcroft-Gault(CG)和先前报道的基于肌酐和/或胱抑素C的GFR估计方程的“偏差”、“精密度”和“准确度”。CKD-EPI肌酸-胱抑素C方程的准确度[各受试者MGFR与估计GFR、MGFR与CrCl、MGFR与CG方程之间的差值]的均方根误差(RMSE=23.56)明显好于CrCl37.69(P=0.001)、CG(RMSE=36.12,P=0.002)和仅基于胱抑素C的GFR估计方程。以与mGFR相差大于30%的EGFR百分比来量化其准确性,其准确性明显好于CrCl4(P=0.024)、CG(P=0.0001)、4变量MDRD(P=0.027)和CKD-EPI肌酸酐2009年(P=0.012)方程。然而,对于23.61%的受试者,由CKD-EPI肌酐-胱抑素C方程估计的GFR与mGFR相差超过30%。CKD-EPI-肌酐-胱抑素C方程(2012)对肝硬变患者的诊断性能优于传统方程在估计GFR方面的临床应用。然而,它的诊断性能比报道的非肝硬变患者要差得多。
Conventional creatinine-based glomerular filtration rate (GFR) equations are insufficiently accurate for estimating GFR in cirrhosis. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) recently proposed an equation to estimate GFR in subjects without cirrhosis using both serum creatinine and cystatin C levels. Performance of the new CKD-EPI creatinine-cystatin C equation (2012) was superior to previous creatinine- or cystatin C-based GFR equations. To evaluate the performance of the CKD-EPI creatinine-cystatin C equation in subjects with cirrhosis, we compared it to GFR measured by non-radiolabeled iothalamate plasma clearance (mGFR) in 72 subjects with cirrhosis. We compared the “bias”, “precision” and “accuracy” of the new CKD-EPI creatinine-cystatin C equation to that of 24-hour urinary creatinine clearance (CrCl), Cockcroft-Gault (CG) and previously reported creatinine- and/or cystatin C-based GFR-estimating equations. Accuracy of CKD-EPI creatinine-cystatin C equation as quantified by root mean squared error of difference scores [differences between mGFR and estimated GFR (eGFR) or between mGFR and CrCl, or between mGFR and CG equation for each subject] (RMSE=23.56) was significantly better than that of CrCl (37.69, P=0.001), CG (RMSE=36.12, P=0.002) and GFR-estimating equations based on cystatin C only. Its accuracy as quantified by percentage of eGFRs that differed by greater than 30% with respect to mGFR was significantly better compared to CrCl (P=0.024), CG (P=0.0001), 4-variable MDRD (P=0.027) and CKD-EPI creatinine 2009 (P=0.012) equations. However, for 23.61% of the subjects, GFR estimated by CKD-EPI creatinine-cystatin C equation differed from the mGFR by more than 30%. The diagnostic performance of CKD-EPI creatinine-cystatin C equation (2012) in patients with cirrhosis was superior to conventional equations in clinical practice for estimating GFR. However, its diagnostic performance was substantially worse than reported in subjects without cirrhosis.
DOI: 10.1001/archinte.1916.00080130010002
发表时间: 1916-06-01
影响因子: --
作者:
Du Bois, D;Du Bois, EF
通讯作者: Du Bois, EF
DOI: 10.1056/nejmoa1114248
发表时间: 2012-07-05
期刊: The New England journal of medicine
影响因子: --
作者:
Inker LA;Schmid CH;Tighiouart H;Eckfeldt JH;Feldman HI;Greene T;Kusek JW;Manzi J;Van Lente F;Zhang YL;Coresh J;Levey AS;CKD-EPI Investigators
通讯作者: CKD-EPI Investigators
DOI: 10.1080/00365510410003723
发表时间: 2004-02-01
影响因子: 2.1
作者:
Larsson, A;Malm, J;Hansson, LO
通讯作者: Hansson, LO
DOI: 10.1136/gut.50.1.106
发表时间: 2002-01-01
期刊: GUT
影响因子: 24.5
作者:
Gerbes, AL;Gülberg, V;Vogeser, M
通讯作者: Vogeser, M
DOI: 10.1172/jci102539
发表时间: 1951-01-01
影响因子: 15.9
作者:
LESLIE, SH;JOHNSTON, B;RALLI, EP
通讯作者: RALLI, EP